Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 241
  • Home
  • Print this page
  • Email this page

    Article Cited by others

REVIEW ARTICLE

Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents

Wilkes Gail M

Year : 2018| Volume: 5| Issue : 2 | Page no: 137-155

   This article has been cited by
 
1 Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial
Jin Li,Weijian Guo,Yuxian Bai,Yanhong Deng,Lei Yang,Zhendong Chen,Haijun Zhong,Ruihua Xu,Hongming Pan,Yongqian Shu,Ying Yuan,Jianfeng Zhou,Nong Xu,Tianshu Liu,Dong Ma,Changping Wu,Ying Cheng,Jianming Xu,Donghui Chen,Wei Li,Sanyuan Sun,Zhuang Yu,Peiguo Cao,Lin Shen,Haihui Chen,Shubin Wang,Hongbing Wang,Songhua Fan,Xiaojun Guo,Ning Wang,Rubing Han,Bin Zhang,Shukui Qin
Advances in Therapy. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 A novel TJP1-ROS1 fusion in malignant peripheral nerve sheath tumor responding to crizotinib
Juming Li,Lingxiang Liu,Qi Zhang,Yumin Huang,Yihong Zhang,Xiaoyan Gan,Siqin Liu,Zhen Yue,Yongzhong Wei
Medicine. 2020; 99(26): e20725
[Pubmed]  [Google Scholar] [DOI]
3 Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
Eunus S. Ali,Shazid Md. Sharker,Muhammad Torequl Islam,Ishaq N. Khan,Subrata Shaw,Md. Atiqur Rahman,Shaikh Jamal Uddin,Manik Chandra Shill,Shahnawaz Rehman,Niranjan Das,Saheem Ahmad,Jamil A. Shilpi,Swati Tripathi,Siddhartha Kumar Mishra,Mohammad S. Mubarak
Seminars in Cancer Biology. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Ocular and orbital side effects of ALK inhibitors: a review article
Elias Chelala,Sandra Hoyek,Nicolas Arej,Joseph Kattan,Hampig Raphael Kourie,Josette Baakliny,Joelle Antoun
Future Oncology. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—A single institution experience and a review of literature
Hira Shaikh,Ahmed Khattab,Muhammad S Faisal,Abhishek Chilkulwar,Mary Albrethsen,Santhosh Sadashiv,Salman Fazal
Journal of Oncology Pharmacy Practice. 2019; 25(5): 1265
[Pubmed]  [Google Scholar] [DOI]
6 Potential use of Pichia pastoris strain SMD1168H expressing DNA topoisomerase I in the screening of potential anti-breast cancer agents
Xin Jian,Wan Wan Mahtar,Siah Poh Chiew,Noorizan Miswan,Khoo Boon Yin
Molecular Medicine Reports. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Novel Targeted Anti-Tumor Nanoparticles Developed from Folic Acid-Modified 2-Deoxyglucose
Shaoming Jin,Zhongyao Du,Huiyuan Guo,Hao Zhang,Fazheng Ren,Pengjie Wang
International Journal of Molecular Sciences. 2019; 20(3): 697
[Pubmed]  [Google Scholar] [DOI]
8 DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
Zhongling Zhu,Peng Chen,Zhao Yan
Thoracic Cancer. 2018; 9(8): 901
[Pubmed]  [Google Scholar] [DOI]

 

Read this article